K120959 is an FDA 510(k) clearance for the BIOPLEX 2200 HSV-1 AND HSV-2 IGG KIT. Classified as Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1 (product code MXJ), Class II - Special Controls.
Submitted by Bio-Rad Laboratories (Benicia, US). The FDA issued a Cleared decision on June 22, 2012 after a review of 84 days - a notably fast clearance cycle.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3305 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.